BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36900256)

  • 21. Impact of guideline adherence on patient outcomes in early-stage epithelial ovarian cancer.
    Lee JY; Kim TH; Suh DH; Kim JW; Kim HS; Chung HH; Park NH; Song YS; Kang SB
    Eur J Surg Oncol; 2015 Apr; 41(4):585-91. PubMed ID: 25624160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry.
    Sung JM; Martin JW; Jefferson FA; Sidhom DA; Piranviseh K; Huang M; Nguyen N; Chang J; Ziogas A; Anton-Culver H; Youssef RF
    Clin Genitourin Cancer; 2019 Oct; 17(5):e995-e1002. PubMed ID: 31239240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment at Academic Centers Decreases Insurance-Based Survival Disparities in Colon Cancer.
    Cabo J; Shu X; Shu XO; Parikh A; Bailey C
    J Surg Res; 2020 Jan; 245():265-272. PubMed ID: 31421372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Quality Metrics for Surgically Treated Laryngeal Squamous Cell Carcinoma.
    Graboyes EM; Townsend ME; Kallogjeri D; Piccirillo JF; Nussenbaum B
    JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1154-1163. PubMed ID: 27435696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian cancer in California: Guideline adherence, survival, and the impact of geographic location, 1996-2014.
    Villanueva C; Chang J; Ziogas A; Bristow RE; Vieira VM
    Cancer Epidemiol; 2020 Dec; 69():101825. PubMed ID: 33022472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving NCCN guideline-adherent care for ovarian cancer: Value of an intervention.
    Dottino JA; Cliby WA; Myers ER; Bristow RE; Havrilesky LJ
    Gynecol Oncol; 2015 Sep; 138(3):694-9. PubMed ID: 26072441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Females Have Worse Overall and Disease-Specific Survival in Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma.
    Hunter WP; Harris JA; Lee CC; Cheng AC; Peacock ZS
    J Oral Maxillofac Surg; 2022 Jul; 80(7):1260-1271. PubMed ID: 35469827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Racial disparities in receipt of standard chemoradiation in anal squamous cell carcinoma, an analysis of the National Cancer Database.
    Bian SX; Chen DH; Lin E
    Cancer Med; 2021 Jan; 10(2):575-585. PubMed ID: 33305908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does race impact survival for patients with anal squamous cell carcinoma?
    Fields AC; Welten VM; Lu P; Goldberg JE; Irani J; Bleday R; Melnitchouk N
    J Surg Oncol; 2019 Dec; 120(7):1201-1207. PubMed ID: 31549446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of gender and HPV status on anal squamous cell carcinoma survival.
    Baidoun F; Saad AM; Abdel-Rahman O
    Int J Colorectal Dis; 2021 Oct; 36(10):2093-2109. PubMed ID: 33787999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disparities in sinonasal squamous cell carcinoma short- and long-term outcomes: Analysis from the national cancer database.
    Carey RM; Parasher AK; Workman AD; Yan CH; Glicksman JT; Chen J; Palmer JN; Adappa ND; Newman JG; Brant JA
    Laryngoscope; 2018 Mar; 128(3):560-567. PubMed ID: 28815617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Insurance and Community-Level Socioeconomic Status With Treatment and Outcome of Squamous Cell Carcinoma of the Pharynx.
    Shin JY; Yoon JK; Shin AK; Blumenfeld P; Mai M; Diaz AZ
    JAMA Otolaryngol Head Neck Surg; 2017 Sep; 143(9):899-907. PubMed ID: 28662244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer.
    Hodeib M; Chang J; Liu F; Ziogas A; Dilley S; Randall LM; Anton-Culver H; Bristow RE
    Gynecol Oncol; 2015 Jul; 138(1):121-7. PubMed ID: 25913132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in guideline-adherent chemoradiation therapy for locally advanced cervical cancer before and after the affordable care act.
    Thomas RJ; Provenzano D; Goyal S; Loew M; Lopez-Acevedo M; Long B; Chappell NP; Rao YJ
    Gynecol Oncol; 2022 Jul; 166(1):165-172. PubMed ID: 35491268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
    Ahmed HZ; Liu Y; O'Connell K; Ahmed MZ; Cassidy RJ; Gillespie TW; Patel P; Pillai RN; Behera M; Steuer CE; Owonikoko TK; Ramalingam SS; Curran WJ; Higgins KA
    Clin Lung Cancer; 2017 Nov; 18(6):706-718. PubMed ID: 28601387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer.
    Kole AJ; Stahl JM; Park HS; Khan SA; Johung KL
    J Natl Compr Canc Netw; 2017 Mar; 15(3):355-362. PubMed ID: 28275036
    [No Abstract]   [Full Text] [Related]  

  • 37. Racial-Ethnic Comparison of Guideline-Adherent Gynecologic Cancer Care in an Equal-Access System.
    Eaglehouse YL; Darcy KM; Tian C; Casablanca Y; Shriver CD; Zhu K
    Obstet Gynecol; 2021 Apr; 137(4):629-640. PubMed ID: 33706355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Racial and economic disparities in the treatment of penile squamous cell carcinoma: Results from the National Cancer Database.
    Sharma P; Ashouri K; Zargar-Shoshtari K; Luchey AM; Spiess PE
    Urol Oncol; 2016 Mar; 34(3):122.e9-15. PubMed ID: 26547834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
    Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
    Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervical Cancer in Sub-Saharan Africa: A Multinational Population-Based Cohort Study of Care and Guideline Adherence.
    Griesel M; Seraphin TP; Mezger NCS; Hämmerl L; Feuchtner J; Joko-Fru WY; Sengayi-Muchengeti M; Liu B; Vuma S; Korir A; Chesumbai GC; Nambooze S; Lorenzoni CF; Akele-Akpo MT; Ayemou A; Traoré CB; Wondemagegnehu T; Wienke A; Thomssen C; Parkin DM; Jemal A; Kantelhardt EJ
    Oncologist; 2021 May; 26(5):e807-e816. PubMed ID: 33565668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.